{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:04:22Z","timestamp":1794373462052,"version":"4.9.0"},"reference-count":237,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05517-w","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T07:57:37Z","timestamp":1764316657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Nrf2\/Keap1 Signaling Axis in the Brain: Master Regulator of Oxidative Stress in Neurodegenerative and Psychiatric Disorders"],"prefix":"10.1007","volume":"63","author":[{"given":"Falguni","family":"Goel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachchida Nand","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmendra Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"17","key":"5517_CR1","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1002\/1873-3468.14840","volume":"598","author":"F Di Domenico","year":"2024","unstructured":"Di Domenico F, Lanzillotta C, Perluigi M (2024) Redox imbalance and metabolic defects in the context of Alzheimer disease. FEBS Lett 598(17):2047\u20132066","journal-title":"FEBS Lett"},{"issue":"1","key":"5517_CR2","doi-asserted-by":"publisher","first-page":"1225578","DOI":"10.1155\/2022\/1225578","volume":"2022","author":"AJPO de Almeida","year":"2022","unstructured":"de Almeida AJPO et al (2022) ROS: basic concepts, sources, cellular signaling, and its implications in aging pathways. Oxid Med Cell Longev 2022(1):1225578","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"5517_CR3","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1007\/s11033-022-07219-1","volume":"49","author":"M Hemagirri","year":"2022","unstructured":"Hemagirri M, Sasidharan S (2022) Biology of aging: oxidative stress and RNA oxidation. Mol Biol Rep 49(6):5089\u20135105","journal-title":"Mol Biol Rep"},{"issue":"1","key":"5517_CR4","volume":"2019","author":"G Cenini","year":"2019","unstructured":"Cenini G, Lloret A, Cascella R (2019) Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view. Oxid Med Cell Longev 2019(1):2105607","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"5517_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12325-019-01148-5","volume":"37","author":"M Rekatsina","year":"2020","unstructured":"Rekatsina M et al (2020) Pathophysiology and therapeutic perspectives of oxidative stress and neurodegenerative diseases: a narrative review. Adv Ther 37(1):113\u2013139","journal-title":"Adv Ther"},{"key":"5517_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","volume":"71","author":"T Alqahtani","year":"2023","unstructured":"Alqahtani T et al (2023) Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and amyotrophic lateral sclerosis-an updated review. Mitochondrion 71:83\u201392","journal-title":"Mitochondrion"},{"issue":"1","key":"5517_CR7","volume":"2014","author":"G Pagano","year":"2014","unstructured":"Pagano G et al (2014) Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies. Oxid Med Cell Longev 2014(1):541230","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"5517_CR8","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","volume":"98","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto M, Kensler TW, Motohashi H (2018) The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev 98(3):1169\u20131203","journal-title":"Physiol Rev"},{"key":"5517_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.826204","volume":"10","author":"J Zhou","year":"2022","unstructured":"Zhou J, Zheng Q, Chen Z (2022) The Nrf2 pathway in liver diseases. Front Cell Dev Biol 10:826204","journal-title":"Front Cell Dev Biol"},{"key":"5517_CR10","doi-asserted-by":"crossref","unstructured":"Joof AN, Bajinka O, Zhou Y, Ren F, Tan Y (2025) The central role of NRF2 in cancer metabolism and redox signaling: novel insights into crosstalk with ER stress and therapeutic modulation. Cell Biochem Biophys:1\u201317","DOI":"10.1007\/s12013-025-01821-3"},{"issue":"1","key":"5517_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00402-y","volume":"8","author":"B Xiao","year":"2022","unstructured":"Xiao B, Kuruvilla J, Tan E-K (2022) Mitophagy and reactive oxygen species interplay in Parkinson\u2019s disease. NPJ Parkinsons Dis 8(1):135","journal-title":"NPJ Parkinsons Dis"},{"issue":"8","key":"5517_CR12","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.3390\/biomedicines10081788","volume":"10","author":"P B\u00e9nit","year":"2022","unstructured":"B\u00e9nit P et al (2022) Succinate dehydrogenase, succinate, and superoxides: a genetic, epigenetic, metabolic, environmental explosive crossroad. Biomedicines 10(8):1788","journal-title":"Biomedicines"},{"issue":"24","key":"5517_CR13","doi-asserted-by":"publisher","first-page":"17223","DOI":"10.3390\/ijms242417223","volume":"24","author":"D Tonev","year":"2023","unstructured":"Tonev D, Momchilova A (2023) Oxidative stress and the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway in multiple sclerosis: focus on certain exogenous and endogenous Nrf2 activators and therapeutic plasma exchange modulation. Int J Mol Sci 24(24):17223","journal-title":"Int J Mol Sci"},{"key":"5517_CR14","doi-asserted-by":"publisher","first-page":"1558263","DOI":"10.3389\/fimmu.2025.1558263","volume":"16","author":"KP Michalak","year":"2025","unstructured":"Michalak KP, Michalak AZ (2025) Understanding chronic inflammation: couplings between cytokines, ROS, NO, Cai 2+, HIF-1\u03b1, Nrf2 and autophagy. Front Immunol 16:1558263","journal-title":"Front Immunol"},{"issue":"1","key":"5517_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12906-018-2340-4","volume":"18","author":"A Prasansuklab","year":"2018","unstructured":"Prasansuklab A, Tencomnao T (2018) Acanthus ebracteatus leaf extract provides neuronal cell protection against oxidative stress injury induced by glutamate. BMC Complement Altern Med 18(1):278","journal-title":"BMC Complement Altern Med"},{"key":"5517_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.787258","volume":"15","author":"S Saha","year":"2022","unstructured":"Saha S et al (2022) A perspective on Nrf2 signaling pathway for neuroinflammation: a potential therapeutic target in Alzheimer\u2019s and Parkinson\u2019s diseases. Front Cell Neurosci 15:787258","journal-title":"Front Cell Neurosci"},{"issue":"7","key":"5517_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10071069","volume":"10","author":"F Villavicencio Tejo","year":"2021","unstructured":"Villavicencio Tejo F, Quintanilla RA (2021) Contribution of the Nrf2 pathway on oxidative damage and mitochondrial failure in Parkinson and Alzheimer\u2019s disease. Antioxidants 10(7):1069","journal-title":"Antioxidants"},{"key":"5517_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neuroscience.2014.11.047","volume":"286","author":"X Jing","year":"2015","unstructured":"Jing X et al (2015) Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson\u2019s disease by enhancing Nrf2 activity. Neuroscience 286:131\u2013140","journal-title":"Neuroscience"},{"issue":"5","key":"5517_CR19","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1159\/000491465","volume":"47","author":"S Paladino","year":"2018","unstructured":"Paladino S et al (2018) Nrf2 pathway in age-related neurological disorders: insights into MicroRNAs. Cell Physiol Biochem 47(5):1951\u20131976","journal-title":"Cell Physiol Biochem"},{"key":"5517_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101619","volume":"77","author":"R Bai","year":"2022","unstructured":"Bai R et al (2022) Oxidative stress: the core pathogenesis and mechanism of Alzheimer\u2019s disease. Ageing Res Rev 77:101619","journal-title":"Ageing Res Rev"},{"issue":"1\u20132","key":"5517_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.psychres.2014.04.005","volume":"218","author":"NC Brown","year":"2014","unstructured":"Brown NC, Andreazza AC, Young LT (2014) An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatr Res 218(1\u20132):61\u201368","journal-title":"Psychiatr Res"},{"issue":"2","key":"5517_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/14728222.2021.1887141","volume":"25","author":"R Bhandari","year":"2021","unstructured":"Bhandari R et al (2021) The Nrf2 pathway in psychiatric disorders: pathophysiological role and potential targeting. Expert Opin Ther Targets 25(2):115\u2013139","journal-title":"Expert Opin Ther Targets"},{"issue":"5","key":"5517_CR23","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1007\/s12035-020-02212-w","volume":"58","author":"G Morris","year":"2021","unstructured":"Morris G et al (2021) Increasing Nrf2 activity as a treatment approach in neuropsychiatry. Mol Neurobiol 58(5):2158\u20132182","journal-title":"Mol Neurobiol"},{"issue":"3","key":"5517_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.tips.2022.12.003","volume":"44","author":"AT Dinkova-Kostova","year":"2023","unstructured":"Dinkova-Kostova AT, Copple IM (2023) Advances and challenges in therapeutic targeting of NRF2. Trends Pharmacol Sci 44(3):137\u2013149","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"5517_CR25","doi-asserted-by":"publisher","DOI":"10.31083\/FBL28286","volume":"30","author":"S Saha","year":"2025","unstructured":"Saha S et al (2025) Elucidating the role of Nrf2 signaling pathway in Mycoplasma infections. Frontiers in Bioscience-Landmark 30(4):28286","journal-title":"Frontiers in Bioscience-Landmark"},{"issue":"1","key":"5517_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41420-025-02491-z","volume":"11","author":"X Yang","year":"2025","unstructured":"Yang X et al (2025) Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment. Cell Death Discov 11(1):189","journal-title":"Cell Death Discov"},{"key":"5517_CR27","doi-asserted-by":"publisher","first-page":"175909141989978","DOI":"10.1177\/1759091419899782","volume":"12","author":"MS Brandes","year":"2020","unstructured":"Brandes MS, Gray NE (2020) NRF2 as a therapeutic target in neurodegenerative diseases. ASN Neuro 12:1759091419899782","journal-title":"ASN Neuro"},{"key":"5517_CR28","doi-asserted-by":"publisher","unstructured":"Kaur G et al (2024) Nanotechnology and CRISPR\/Cas-Mediated Gene Therapy Strategies: Potential Role for Treating Genetic Disorders. Molecular Biotechnol. 1-23https:\/\/doi.org\/10.1007\/s12033-024-01301-8","DOI":"10.1007\/s12033-024-01301-8"},{"issue":"3","key":"5517_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11011-023-01224-4","volume":"39","author":"A Shah","year":"2024","unstructured":"Shah A, Varma M, Bhandari R (2024) Exploring sulforaphane as neurotherapeutic: targeting Nrf2-Keap & Nf-Kb pathway crosstalk in ASD. Metab Brain Dis 39(3):373\u2013385","journal-title":"Metab Brain Dis"},{"issue":"19","key":"5517_CR30","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1111\/febs.14379","volume":"285","author":"AT Dinkova-Kostova","year":"2018","unstructured":"Dinkova-Kostova AT, Kostov RV, Kazantsev AG (2018) The role of Nrf2 signaling in counteracting neurodegenerative diseases. FEBS J 285(19):3576\u20133590","journal-title":"FEBS J"},{"key":"5517_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.865772","volume":"13","author":"B Tastan","year":"2022","unstructured":"Tastan B, Arioz BI, Genc S (2022) Targeting NLRP3 inflammasome with Nrf2 inducers in central nervous system disorders. Front Immunol 13:865772","journal-title":"Front Immunol"},{"issue":"9","key":"5517_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-02124-4","volume":"40","author":"AG Mukherjee","year":"2023","unstructured":"Mukherjee AG, Gopalakrishnan AV (2023) The mechanistic insights of the antioxidant Keap1-Nrf2 pathway in oncogenesis: a deadly scenario. Med Oncol 40(9):248","journal-title":"Med Oncol"},{"issue":"1","key":"5517_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02100-6","volume":"4","author":"Y Horie","year":"2021","unstructured":"Horie Y et al (2021) Molecular basis for the disruption of Keap1\u2013Nrf2 interaction via hinge & latch mechanism. Commun Biol 4(1):576","journal-title":"Commun Biol"},{"key":"5517_CR34","doi-asserted-by":"publisher","DOI":"10.15421\/022074","author":"V Bityutsky","year":"2020","unstructured":"Bityutsky V et al (2020) Regulation of redox processes in biological systems with the participation of the Keap1\/Nrf2\/ARE signaling pathway, biogenic selenium nanoparticles as Nrf2 activators. Regul Mech Biosyst. https:\/\/doi.org\/10.15421\/022074","journal-title":"Regul Mech Biosyst"},{"issue":"6","key":"5517_CR35","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.chembiol.2023.12.005","volume":"31","author":"M Lu","year":"2024","unstructured":"Lu M et al (2024) Bivalent inhibitors of the BTB E3 ligase KEAP1 enable instant NRF2 activation to suppress acute inflammatory response. Cell Chem Biol 31(6):1188-1202. e10","journal-title":"Cell Chem Biol"},{"issue":"2","key":"5517_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1128\/MCB.00868-15","volume":"36","author":"R Saito","year":"2016","unstructured":"Saito R et al (2016) Characterizations of three major cysteine sensors of Keap1 in stress response. Mol Cell Biol 36(2):271\u2013284","journal-title":"Mol Cell Biol"},{"key":"5517_CR37","doi-asserted-by":"publisher","first-page":"1332049","DOI":"10.3389\/fcell.2023.1332049","volume":"11","author":"Y Song","year":"2024","unstructured":"Song Y et al (2024) Post-translational modifications of Keap1: the state of the art. Front Cell Dev Biol 11:1332049","journal-title":"Front Cell Dev Biol"},{"key":"5517_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41573-025-01145-0","volume":"24","author":"DD Zhang","year":"2025","unstructured":"Zhang DD (2025) Thirty years of NRF2: advances and therapeutic challenges. Nat Rev Drug Discov:1\u201324","journal-title":"Nat Rev Drug Discov"},{"key":"5517_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113820","volume":"173","author":"JW Shin","year":"2020","unstructured":"Shin JW et al (2020) Curcumin induces stabilization of Nrf2 protein through Keap1 cysteine modification. Biochem Pharmacol 173:113820","journal-title":"Biochem Pharmacol"},{"issue":"20","key":"5517_CR40","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00273-19","volume":"39","author":"F Katsuoka","year":"2019","unstructured":"Katsuoka F et al (2019) Direct and specific functional evaluation of the Nrf2 and MafG heterodimer by introducing a tethered dimer into small Maf-deficient cells. Mol Cell Biol 39(20):e00273-e319","journal-title":"Mol Cell Biol"},{"issue":"1","key":"5517_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6635460","volume":"2021","author":"C Yu","year":"2021","unstructured":"Yu C, Xiao J-H (2021) The Keap1-Nrf2 system: a mediator between oxidative stress and aging. Oxid Med Cell Longev 2021(1):6635460","journal-title":"Oxid Med Cell Longev"},{"key":"5517_CR42","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.freeradbiomed.2018.04.550","volume":"120","author":"A Mathur","year":"2018","unstructured":"Mathur A, Pandey VK, Kakkar P (2018) Activation of GSK3\u03b2\/\u03b2-TrCP axis via PHLPP1 exacerbates Nrf2 degradation leading to impairment in cell survival pathway during diabetic nephropathy. Free Radic Biol Med 120:414\u2013424","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"5517_CR43","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1002\/jcp.29219","volume":"235","author":"P Shaw","year":"2020","unstructured":"Shaw P, Chattopadhyay A (2020) Nrf2\u2013ARE signaling in cellular protection: mechanism of action and the regulatory mechanisms. J Cell Physiol 235(4):3119\u20133130","journal-title":"J Cell Physiol"},{"issue":"4","key":"5517_CR44","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.bbrc.2020.02.006","volume":"524","author":"A Ganner","year":"2020","unstructured":"Ganner A et al (2020) The acetyltransferase p300 regulates NRF2 stability and localization. Biochem Biophys Res Commun 524(4):895\u2013902","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"5517_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1134\/S1022795424701485","volume":"61","author":"A Gureev","year":"2025","unstructured":"Gureev A, Krutskikh E (2025) Regulation of the NRF2 transcription factor activity by SIRT1-induced deacetylation: a possible SIRT1\u2013NRF2 feedback loop. Russ J Genet 61(2):133\u2013139","journal-title":"Russ J Genet"},{"key":"5517_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102726","volume":"63","author":"S Adinolfi","year":"2023","unstructured":"Adinolfi S et al (2023) The KEAP1-NRF2 pathway: targets for therapy and role in cancer. Redox Biol 63:102726","journal-title":"Redox Biol"},{"issue":"9","key":"5517_CR47","doi-asserted-by":"publisher","first-page":"9023","DOI":"10.1007\/s11033-022-07778-3","volume":"49","author":"A Verma","year":"2022","unstructured":"Verma A et al (2022) Molecular mechanisms regulating the pharmacological actions of icariin with special focus on PI3K-AKT and Nrf-2 signaling pathways. Mol Biol Rep 49(9):9023\u20139032","journal-title":"Mol Biol Rep"},{"issue":"7","key":"5517_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14818","volume":"30","author":"J Zhao","year":"2024","unstructured":"Zhao J et al (2024) GSK3: a potential target and pending issues for treatment of Alzheimer\u2019s disease. CNS Neurosci Ther 30(7):e14818","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"5517_CR49","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10571-020-01009-8","volume":"41","author":"J Guo","year":"2021","unstructured":"Guo J et al (2021) Involvement of \u03b17nAChR in the protective effects of genistein against \u03b2-amyloid-induced oxidative stress in neurons via a PI3K\/Akt\/Nrf2 pathway-related mechanism. Cell Mol Neurobiol 41(2):377\u2013393","journal-title":"Cell Mol Neurobiol"},{"issue":"10","key":"5517_CR50","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1007\/s00204-024-03829-9","volume":"98","author":"PK Keshri","year":"2024","unstructured":"Keshri PK, Singh SP (2024) Unraveling the AKT\/ERK cascade and its role in Parkinson disease. Arch Toxicol 98(10):3169\u20133190","journal-title":"Arch Toxicol"},{"issue":"22","key":"5517_CR51","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/molecules25225474","volume":"25","author":"S Saha","year":"2020","unstructured":"Saha S et al (2020) An overview of Nrf2 signaling pathway and its role in inflammation. Molecules 25(22):5474","journal-title":"Molecules"},{"key":"5517_CR52","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S494550","author":"J Liu","year":"2025","unstructured":"Liu J, Wang M, Zhao Y (2025) The regulatory network of transcription factors in macrophage polarization. Immunotargets Ther. https:\/\/doi.org\/10.2147\/ITT.S494550","journal-title":"Immunotargets Ther"},{"issue":"7","key":"5517_CR53","doi-asserted-by":"publisher","first-page":"6868","DOI":"10.3390\/cimb46070410","volume":"46","author":"F Armeli","year":"2024","unstructured":"Armeli F et al (2024) Interplay among oxidative stress, autophagy, and the endocannabinoid system in neurodegenerative diseases: role of the Nrf2-p62\/SQSTM1 pathway and nutraceutical activation. Curr Issues Mol Biol 46(7):6868\u20136884","journal-title":"Curr Issues Mol Biol"},{"issue":"11","key":"5517_CR54","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1080\/15548627.2024.2374692","volume":"20","author":"E-J Choi","year":"2024","unstructured":"Choi E-J et al (2024) Metabolic stress induces a double-positive feedback loop between AMPK and SQSTM1\/p62 conferring dual activation of AMPK and NFE2L2\/NRF2 to synergize antioxidant defense. Autophagy 20(11):2490\u20132510","journal-title":"Autophagy"},{"issue":"1","key":"5517_CR55","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/biom15010113","volume":"15","author":"B Buttari","year":"2025","unstructured":"Buttari B et al (2025) Proteostasis decline and redox imbalance in age-related diseases: the therapeutic potential of NRF2. Biomolecules 15(1):113","journal-title":"Biomolecules"},{"key":"5517_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103700","volume":"84","author":"X Quan","year":"2025","unstructured":"Quan X et al (2025) Autophagy hub-protein p62 orchestrates oxidative, endoplasmic reticulum stress, and inflammatory responses post-ischemia, exacerbating stroke outcome. Redox Biol 84:103700","journal-title":"Redox Biol"},{"issue":"1","key":"5517_CR57","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9971885","volume":"2021","author":"MA Akanji","year":"2021","unstructured":"Akanji MA et al (2021) Redox homeostasis and prospects for therapeutic targeting in neurodegenerative disorders. Oxid Med Cell Longev 2021(1):9971885","journal-title":"Oxid Med Cell Longev"},{"key":"5517_CR58","first-page":"1","volume":"1","author":"MZ Baba","year":"2021","unstructured":"Baba MZ, Gowmathy S, Wahedi U (2021) Therapeutic potential of NRF2 pathway in neurological disorder. Datess 1:1\u201310","journal-title":"Datess"},{"issue":"9","key":"5517_CR59","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.3390\/molecules26092424","volume":"26","author":"I S\u00fcntar","year":"2021","unstructured":"S\u00fcntar I et al (2021) Regulatory role of Nrf2 signaling pathway in wound healing process. Molecules 26(9):2424","journal-title":"Molecules"},{"issue":"17","key":"5517_CR60","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1089\/ars.2017.7342","volume":"29","author":"C Tonelli","year":"2018","unstructured":"Tonelli C, Chio IIC, Tuveson DA (2018) Transcriptional regulation by Nrf2. Antioxid Redox Signal 29(17):1727\u20131745","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"5517_CR61","doi-asserted-by":"publisher","first-page":"133","DOI":"10.14348\/molcells.2023.0028","volume":"46","author":"T Suzuki","year":"2023","unstructured":"Suzuki T, Takahashi J, Yamamoto M (2023) Molecular basis of the KEAP1-NRF2 signaling pathway. Mol Cells 46(3):133\u2013141","journal-title":"Mol Cells"},{"issue":"15","key":"5517_CR62","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2217\/epi-2023-0207","volume":"15","author":"C Wu","year":"2023","unstructured":"Wu C et al (2023) Advances in the role of epigenetics in homocysteine-related diseases. Epigenomics 15(15):769\u2013795","journal-title":"Epigenomics"},{"issue":"9","key":"5517_CR63","doi-asserted-by":"publisher","first-page":"2000288","DOI":"10.1002\/bies.202000288","volume":"43","author":"RH Morris","year":"2021","unstructured":"Morris RH et al (2021) Early life exposure to air pollution impacts neuronal and glial cell function leading to impaired neurodevelopment. Bioessays 43(9):2000288","journal-title":"Bioessays"},{"issue":"12","key":"5517_CR64","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.3390\/antiox13121502","volume":"13","author":"E Navarro","year":"2024","unstructured":"Navarro E, Esteras N (2024) Multitarget effects of Nrf2 signalling in the brain: common and specific functions in different cell types. Antioxidants 13(12):1502","journal-title":"Antioxidants"},{"issue":"2","key":"5517_CR65","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12031-025-02357-0","volume":"75","author":"A Pal","year":"2025","unstructured":"Pal A, Goel F, Garg VK (2025) From genetics to function: the role of ABCA12 in autism neurobiology. J Mol Neurosci 75(2):67","journal-title":"J Mol Neurosci"},{"issue":"8","key":"5517_CR66","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3390\/antiox11081426","volume":"11","author":"T Heurtaux","year":"2022","unstructured":"Heurtaux T et al (2022) Normal and pathological NRF2 signalling in the central nervous system. Antioxidants 11(8):1426","journal-title":"Antioxidants"},{"issue":"2","key":"5517_CR67","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11011-025-01552-7","volume":"40","author":"M Kaur","year":"2025","unstructured":"Kaur M, Aran KR (2025) Unraveling the role of Nrf2 in dopaminergic neurons: a review of oxidative stress and mitochondrial dysfunction in Parkinson\u2019s disease. Metab Brain Dis 40(2):123","journal-title":"Metab Brain Dis"},{"issue":"9","key":"5517_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098059","volume":"24","author":"D P\u00e9rez-Sala","year":"2023","unstructured":"P\u00e9rez-Sala D, Pajares MA (2023) Appraising the role of astrocytes as suppliers of neuronal glutathione precursors. Int J Mol Sci 24(9):8059","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5517_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12781","volume":"53","author":"Y Chen","year":"2020","unstructured":"Chen Y et al (2020) The role of astrocytes in oxidative stress of central nervous system: a mixed blessing. Cell Prolif 53(3):e12781","journal-title":"Cell Prolif"},{"issue":"7","key":"5517_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250232","volume":"53","author":"P Petry","year":"2023","unstructured":"Petry P, Oschwald A, Kierdorf K (2023) Microglial tissue surveillance: the never-resting gardener in the developing and adult CNS. Eur J Immunol 53(7):2250232","journal-title":"Eur J Immunol"},{"issue":"5","key":"5517_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47050344","volume":"47","author":"S Wang","year":"2025","unstructured":"Wang S et al (2025) Balancing microglial density and activation in central nervous system development and disease. Curr Issues Mol Biol 47(5):344","journal-title":"Curr Issues Mol Biol"},{"issue":"2","key":"5517_CR72","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.molmed.2019.09.007","volume":"26","author":"X Dai","year":"2020","unstructured":"Dai X et al (2020) Nrf2: redox and metabolic regulator of stem cell state and function. Trends Mol Med 26(2):185\u2013200","journal-title":"Trends Mol Med"},{"issue":"2","key":"5517_CR73","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/toxres\/tfab007","volume":"10","author":"L Xiong","year":"2021","unstructured":"Xiong L et al (2021) Sodium arsenite induces spatial learning and memory impairment associated with oxidative stress and activates the Nrf2\/PPAR\u03b3 pathway against oxidative injury in mice hippocampus. Toxicol Res 10(2):277\u2013283","journal-title":"Toxicol Res"},{"key":"5517_CR74","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/jnc.13580","volume":"139","author":"JD Sweatt","year":"2016","unstructured":"Sweatt JD (2016) Neural plasticity and behavior\u2013sixty years of conceptual advances. J Neurochem 139:179\u2013199","journal-title":"J Neurochem"},{"issue":"1","key":"5517_CR75","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","volume":"53","author":"PK Kamat","year":"2016","unstructured":"Kamat PK et al (2016) Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer\u2019s disease: understanding the therapeutics strategies. Mol Neurobiol 53(1):648\u2013661","journal-title":"Mol Neurobiol"},{"issue":"1","key":"5517_CR76","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41398-021-01261-6","volume":"11","author":"W Yao","year":"2021","unstructured":"Yao W et al (2021) Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents. Transl Psychiatry 11(1):140","journal-title":"Transl Psychiatry"},{"key":"5517_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2019.110767","volume":"131","author":"JA Zweig","year":"2020","unstructured":"Zweig JA et al (2020) Loss of NRF2 leads to impaired mitochondrial function, decreased synaptic density and exacerbated age-related cognitive deficits. Exp Gerontol 131:110767","journal-title":"Exp Gerontol"},{"issue":"1","key":"5517_CR78","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.asjsur.2022.02.005","volume":"46","author":"D Da","year":"2023","unstructured":"Da D et al (2023) Glutamate-cysteine ligase catalytic and its modifier function as novel immunotargets in gastric adenocarcinoma. Asian J Surg 46(1):143\u2013149","journal-title":"Asian J Surg"},{"issue":"1","key":"5517_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04802-3","volume":"22","author":"L Yuhan","year":"2024","unstructured":"Yuhan L, Khaleghi Ghadiri M, Gorji A (2024) Impact of NQO1 dysregulation in CNS disorders. J Transl Med 22(1):4","journal-title":"J Transl Med"},{"issue":"1","key":"5517_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00524-0","volume":"17","author":"LK Wareham","year":"2022","unstructured":"Wareham LK et al (2022) Solving neurodegeneration: common mechanisms and strategies for new treatments. Mol Neurodegener 17(1):23","journal-title":"Mol Neurodegener"},{"key":"5517_CR81","doi-asserted-by":"crossref","unstructured":"Mustafa YF (2025) Coumarins at the crossroads of drug development: enzyme modulation for clinical advances. Indian J Clin Biochem:1\u201324","DOI":"10.1007\/s12291-025-01331-2"},{"issue":"4","key":"5517_CR82","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chembiol.2020.03.011","volume":"27","author":"A Anandhan","year":"2020","unstructured":"Anandhan A et al (2020) Breakdown of an ironclad defense system: the critical role of NRF2 in mediating ferroptosis. Cell Chem Biol 27(4):436\u2013447","journal-title":"Cell Chem Biol"},{"issue":"6","key":"5517_CR83","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/glia.24343","volume":"71","author":"Y Liu","year":"2023","unstructured":"Liu Y et al (2023) Interactions of glial cells with neuronal synapses, from astrocytes to microglia and oligodendrocyte lineage cells. Glia 71(6):1383\u20131401","journal-title":"Glia"},{"issue":"7","key":"5517_CR84","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00109-021-02071-5","volume":"99","author":"Y Niu","year":"2021","unstructured":"Niu Y, Zhang J, Dong M (2021) Nrf2 as a potential target for Parkinson\u2019s disease therapy. J Mol Med 99(7):917\u2013931","journal-title":"J Mol Med"},{"issue":"1","key":"5517_CR85","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1750-3639.1999.tb00215.x","volume":"9","author":"WR Markesbery","year":"1999","unstructured":"Markesbery WR, Carney JM (1999) Oxidative alterations in Alzheimer\u2019s disease. Brain Pathol 9(1):133\u2013146","journal-title":"Brain Pathol"},{"issue":"9","key":"5517_CR86","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00204-019-02538-y","volume":"93","author":"M Simunkova","year":"2019","unstructured":"Simunkova M et al (2019) Management of oxidative stress and other pathologies in Alzheimer\u2019s disease. Arch Toxicol 93(9):2491\u20132513","journal-title":"Arch Toxicol"},{"key":"5517_CR87","doi-asserted-by":"crossref","unstructured":"Dev P, Pathak A (2024) The current status of cognitive disorders and their diagnosis. In: Cognitive predictive maintenance tools for brain diseases. Chapman and Hall\/CRC, pp 10\u201335","DOI":"10.1201\/9781003245346-2"},{"issue":"1","key":"5517_CR88","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11064-016-1844-x","volume":"41","author":"Z Zhang","year":"2016","unstructured":"Zhang Z et al (2016) Autophagy in neurodegenerative diseases and metal neurotoxicity. Neurochem Res 41(1):409\u2013422","journal-title":"Neurochem Res"},{"key":"5517_CR89","doi-asserted-by":"publisher","first-page":"1217730","DOI":"10.3389\/fendo.2023.1217730","volume":"14","author":"GA Sidiropoulou","year":"2023","unstructured":"Sidiropoulou GA, Metaxas A, Kourti M (2023) Natural antioxidants that act against Alzheimer\u2019s disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action. Front Endocrinol 14:1217730","journal-title":"Front Endocrinol"},{"issue":"7","key":"5517_CR90","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70268","volume":"6","author":"S Liu","year":"2025","unstructured":"Liu S et al (2025) Oxidative stress: signaling pathways, biological functions, and disease. MedComm 6(7):e70268","journal-title":"MedComm"},{"issue":"11","key":"5517_CR91","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1007\/s12035-021-02516-5","volume":"58","author":"Z van Jansen Rensburg","year":"2021","unstructured":"van Jansen Rensburg Z et al (2021) Toxic feedback loop involving iron, reactive oxygen species, \u03b1-synuclein and neuromelanin in Parkinson\u2019s disease and intervention with turmeric. Mol Neurobiol 58(11):5920\u20135936","journal-title":"Mol Neurobiol"},{"issue":"1","key":"5517_CR92","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/bph.15684","volume":"179","author":"ME Haque","year":"2022","unstructured":"Haque ME et al (2022) Targeting \u03b1-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson\u2019s disease. Br J Pharmacol 179(1):23\u201345","journal-title":"Br J Pharmacol"},{"issue":"4","key":"5517_CR93","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s12035-022-03193-8","volume":"60","author":"MT Ibarra-Guti\u00e9rrez","year":"2023","unstructured":"Ibarra-Guti\u00e9rrez MT, Serrano-Garc\u00eda N, Orozco-Ibarra M (2023) Rotenone-induced model of Parkinson\u2019s disease: beyond mitochondrial complex I inhibition. Mol Neurobiol 60(4):1929\u20131948","journal-title":"Mol Neurobiol"},{"issue":"5","key":"5517_CR94","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s10787-024-01549-1","volume":"32","author":"T Kaur","year":"2024","unstructured":"Kaur T et al (2024) Unraveling neuroprotection in Parkinson\u2019s disease: Nrf2\u2013Keap1 pathway\u2019s vital role amidst pathogenic pathways. Inflammopharmacology 32(5):2801\u20132820","journal-title":"Inflammopharmacology"},{"key":"5517_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2025.107521","author":"M Mondal","year":"2025","unstructured":"Mondal M et al (2025) Micro (nano) plastics in the brain: epigenetic perturbations in progression to neurodegenerative diseases. Neurotoxicol Teratol. https:\/\/doi.org\/10.1016\/j.ntt.2025.107521","journal-title":"Neurotoxicol Teratol"},{"issue":"4","key":"5517_CR96","first-page":"293","volume":"33","author":"L Arning","year":"2022","unstructured":"Arning L, Nguyen HP (2022) Huntington disease update: new insights into the role of repeat instability in disease pathogenesis. Med Gen 33(4):293\u2013300","journal-title":"Med Gen"},{"issue":"8","key":"5517_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087221","volume":"24","author":"A Tassone","year":"2023","unstructured":"Tassone A et al (2023) Mitochondrial bioenergy in neurodegenerative disease: Huntington and Parkinson. Int J Mol Sci 24(8):7221","journal-title":"Int J Mol Sci"},{"issue":"23","key":"5517_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315272","volume":"23","author":"P Tucci","year":"2022","unstructured":"Tucci P et al (2022) Nrf2 pathway in Huntington\u2019s disease (HD): what is its role? Int J Mol Sci 23(23):15272","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5517_CR99","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10072-024-07802-3","volume":"46","author":"V Sharma","year":"2025","unstructured":"Sharma V, Sharma P, Singh TG (2025) Mechanistic insights on the role of Nrf-2 signalling in Huntington\u2019s disease. Neurol Sci 46(2):593\u2013604","journal-title":"Neurol Sci"},{"key":"5517_CR100","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-03976-5","author":"F Goel","year":"2025","unstructured":"Goel F, Dobhal V, Singh S (2025) Protective effects of diacerein against quinolinic acid\u2013induced Huntington\u2019s disease\u2013like symptoms in adult zebrafish by targeting GSK-3\u03b2 signalling. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-03976-5","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"5517_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-023-01070-6","volume":"16","author":"RN Stringer","year":"2023","unstructured":"Stringer RN, Weiss N (2023) Pathophysiology of ion channels in amyotrophic lateral sclerosis. Mol Brain 16(1):82","journal-title":"Mol Brain"},{"issue":"16","key":"5517_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169339","volume":"23","author":"A Motataianu","year":"2022","unstructured":"Motataianu A et al (2022) Oxidative stress in amyotrophic lateral sclerosis: synergy of genetic and environmental factors. Int J Mol Sci 23(16):9339","journal-title":"Int J Mol Sci"},{"issue":"17","key":"5517_CR103","doi-asserted-by":"publisher","first-page":"9215","DOI":"10.1002\/anie.202000451","volume":"60","author":"BG Trist","year":"2021","unstructured":"Trist BG et al (2021) Superoxide dismutase 1 in health and disease: how a frontline antioxidant becomes neurotoxic. Angew Chem Int Ed 60(17):9215\u20139246","journal-title":"Angew Chem Int Ed"},{"issue":"5","key":"5517_CR104","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/molecules27051471","volume":"27","author":"L Arslanbaeva","year":"2022","unstructured":"Arslanbaeva L, Bisaglia M (2022) Activation of the Nrf2 pathway as a therapeutic strategy for ALS treatment. Molecules 27(5):1471","journal-title":"Molecules"},{"issue":"1","key":"5517_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00479-8","volume":"16","author":"S Bono","year":"2021","unstructured":"Bono S, Feligioni M, Corbo M (2021) Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy. Mol Neurodegener 16(1):71","journal-title":"Mol Neurodegener"},{"issue":"4","key":"5517_CR106","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13575","volume":"21","author":"B Marchetti","year":"2022","unstructured":"Marchetti B et al (2022) Reframing\u201d dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2\/Wnt driver: therapeutical implications. Aging Cell 21(4):e13575","journal-title":"Aging Cell"},{"issue":"17","key":"5517_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179592","volume":"22","author":"E Zgorzynska","year":"2021","unstructured":"Zgorzynska E, Dziedzic B, Walczewska A (2021) An overview of the Nrf2\/ARE pathway and its role in neurodegenerative diseases. Int J Mol Sci 22(17):9592","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5517_CR108","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","volume":"18","author":"A Cuadrado","year":"2019","unstructured":"Cuadrado A et al (2019) Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov 18(4):295\u2013317","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"5517_CR109","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2174\/1566524023666230726145447","volume":"25","author":"K Kaur","year":"2025","unstructured":"Kaur K, Narang RK, Singh S (2025) Role of Nrf2 in oxidative stress, neuroinflammation and autophagy in Alzheimer\u2019s disease: regulation of Nrf2 by different signaling pathways. Curr Mol Med 25(4):372\u2013387","journal-title":"Curr Mol Med"},{"key":"5517_CR110","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-01839-2","author":"OK Kuwar","year":"2025","unstructured":"Kuwar OK, Singh S (2025) Baicalein-mediated regulation of Nrf2\/ARE, NF\u0138B, and MAPK signaling in Huntington\u2019s disease: a promising strategy against neuroinflammation and neurodegeneration. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-025-01839-2","journal-title":"Inflammopharmacology"},{"issue":"6","key":"5517_CR111","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/molecules30061211","volume":"30","author":"A Russo","year":"2025","unstructured":"Russo A et al (2025) Emerging ferroptosis involvement in amyotrophic lateral sclerosis pathogenesis: neuroprotective activity of polyphenols. Molecules 30(6):1211","journal-title":"Molecules"},{"key":"5517_CR112","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-981-97-2681-3_2","volume-title":"Nutrition and Psychiatric Disorders: An Evidence-Based Approach to Understanding the Diet-Brain Connection","author":"YK Ghallab","year":"2024","unstructured":"Ghallab YK, Elassal OS (2024) Biochemical and neuropharmacology of psychiatric disorders. Nutrition and Psychiatric Disorders: An Evidence-Based Approach to Understanding the Diet-Brain Connection. Springer, pp 25\u201347"},{"issue":"1","key":"5517_CR113","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8881770","volume":"2021","author":"EA Ermakov","year":"2021","unstructured":"Ermakov EA et al (2021) Oxidative stress-related mechanisms in schizophrenia pathogenesis and new treatment perspectives. Oxid Med Cell Longev 2021(1):8881770","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"5517_CR114","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s11033-024-09771-4","volume":"51","author":"J-L Xiao","year":"2024","unstructured":"Xiao J-L et al (2024) Regulation of Keap1-Nrf2 signaling in health and diseases. Mol Biol Rep 51(1):809","journal-title":"Mol Biol Rep"},{"issue":"6","key":"5517_CR115","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/antiox13060709","volume":"13","author":"NS Rawani","year":"2024","unstructured":"Rawani NS et al (2024) The underlying neurobiological mechanisms of psychosis: focus on neurotransmission dysregulation, neuroinflammation, oxidative stress, and mitochondrial dysfunction. Antioxidants 13(6):709","journal-title":"Antioxidants"},{"key":"5517_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-025-01116-4","author":"M Maes","year":"2025","unstructured":"Maes M et al (2025) Neuroimmune, metabolic and oxidative stress pathways in major depressive disorder. Nat Rev Neurol. https:\/\/doi.org\/10.1038\/s41582-025-01116-4","journal-title":"Nat Rev Neurol"},{"key":"5517_CR117","doi-asserted-by":"crossref","unstructured":"Pal A, Goel F, Sharma A, Garg VK (2025) Oxidative stress and antioxidant therapeutics in autism spectrum disorder: a biochemical and structure\u2013activity relationship perspective. Mol Divers:1\u201319","DOI":"10.1007\/s11030-025-11274-8"},{"issue":"3","key":"5517_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032258","volume":"24","author":"A Winiarska-Mieczan","year":"2023","unstructured":"Winiarska-Mieczan A et al (2023) Anti-inflammatory, antioxidant, and neuroprotective effects of polyphenols\u2014polyphenols as an element of diet therapy in depressive disorders. Int J Mol Sci 24(3):2258","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5517_CR119","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/antiox12040817","volume":"12","author":"G Sani","year":"2023","unstructured":"Sani G et al (2023) The Nrf2 pathway in depressive disorders: a systematic review of animal and human studies. Antioxidants 12(4):817","journal-title":"Antioxidants"},{"issue":"11","key":"5517_CR120","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1038\/s41380-023-02260-3","volume":"28","author":"J Kaiser","year":"2023","unstructured":"Kaiser J et al (2023) CaMKK2 as an emerging treatment target for bipolar disorder. Mol Psychiatry 28(11):4500\u20134511","journal-title":"Mol Psychiatry"},{"issue":"31","key":"5517_CR121","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm5500","volume":"8","author":"N Rothammer","year":"2022","unstructured":"Rothammer N et al (2022) G9a dictates neuronal vulnerability to inflammatory stress via transcriptional control of ferroptosis. Sci Adv 8(31):eabm5500","journal-title":"Sci Adv"},{"issue":"7","key":"5517_CR122","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41419-021-03952-w","volume":"12","author":"S Gumeni","year":"2021","unstructured":"Gumeni S et al (2021) Nrf2 activation induces mitophagy and reverses Parkin\/Pink1 knock down-mediated neuronal and muscle degeneration phenotypes. Cell Death Dis 12(7):671","journal-title":"Cell Death Dis"},{"issue":"8","key":"5517_CR123","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.tins.2024.06.008","volume":"47","author":"MM Herting","year":"2024","unstructured":"Herting MM, Bottenhorn KL, Cotter DL (2024) Outdoor air pollution and brain development in childhood and adolescence. Trends Neurosci 47(8):593\u2013607","journal-title":"Trends Neurosci"},{"key":"5517_CR124","doi-asserted-by":"publisher","first-page":"1024649","DOI":"10.3389\/fncel.2022.1024649","volume":"16","author":"J Xu","year":"2022","unstructured":"Xu J et al (2022) The effects and mechanism of environmental enrichment on MK-801 induced cognitive impairment in rodents with schizophrenia. Front Cell Neurosci 16:1024649","journal-title":"Front Cell Neurosci"},{"issue":"14","key":"5517_CR125","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1089\/ars.2020.8238","volume":"35","author":"E Malard","year":"2021","unstructured":"Malard E et al (2021) The reactive species interactome in the brain. Antioxid Redox Signal 35(14):1176\u20131206","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"5517_CR126","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1038\/s41380-024-02503-x","volume":"29","author":"K Allott","year":"2024","unstructured":"Allott K et al (2024) Advancing understanding of the mechanisms of antipsychotic-associated cognitive impairment to minimise harm: a call to action. Mol Psychiatry 29(8):2571\u20132574","journal-title":"Mol Psychiatry"},{"issue":"19","key":"5517_CR127","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1021\/acschemneuro.2c00420","volume":"13","author":"PK Mandal","year":"2022","unstructured":"Mandal PK et al (2022) Schizophrenia, bipolar and major depressive disorders: overview of clinical features, neurotransmitter alterations, pharmacological interventions, and impact of oxidative stress in the disease process. ACS Chem Neurosci 13(19):2784\u20132802","journal-title":"ACS Chem Neurosci"},{"key":"5517_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2023.106078","volume":"151","author":"HEA \u00c7eli\u0307k","year":"2023","unstructured":"\u00c7eli\u0307k HEA et al (2023) A comparative meta-analysis of peripheral 8-hydroxy-2\u2032-deoxyguanosine (8-OHdG) or 8-oxo-7, 8-dihydro-2\u2032-deoxyguanosine (8-oxo-dG) levels across mood episodes in bipolar disorder. Psychoneuroendocrinology 151:106078","journal-title":"Psychoneuroendocrinology"},{"key":"5517_CR129","unstructured":"Kim Y (2014) Symposium I prescription pattern in the treatment of bipolar affective disorder: what the real world is like"},{"issue":"4","key":"5517_CR130","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s43440-022-00390-z","volume":"74","author":"D Soni","year":"2022","unstructured":"Soni D, Kumar P (2022) GSK-3\u03b2-mediated regulation of Nrf2\/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders. Pharmacol Rep 74(4):557\u2013569","journal-title":"Pharmacol Rep"},{"key":"5517_CR131","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05097-9","author":"N-A Lashgari","year":"2025","unstructured":"Lashgari N-A et al (2025) Psychedelics in the treatment of neurologic and psychiatric disorders: coincidence or a new point of view. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-05097-9","journal-title":"Mol Neurobiol"},{"issue":"3","key":"5517_CR132","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/15622975.2016.1190867","volume":"18","author":"B Bandelow","year":"2017","unstructured":"Bandelow B et al (2017) Biological markers for anxiety disorders, OCD and PTSD: a consensus statement. Part II: neurochemistry, neurophysiology and neurocognition. World J Biol Psychiatry 18(3):162\u2013214","journal-title":"World J Biol Psychiatry"},{"issue":"17","key":"5517_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/nu16172856","volume":"16","author":"VE Tseilikman","year":"2024","unstructured":"Tseilikman VE et al (2024) Resveratrol: a multifaceted guardian against anxiety and stress disorders\u2014an overview of experimental evidence. Nutrients 16(17):2856","journal-title":"Nutrients"},{"key":"5517_CR134","doi-asserted-by":"crossref","unstructured":"Viegas FvPD et al (2022) Curcumin, resveratrol and cannabidiol as natural key prototypes in drug design for neuroprotective agents. Current Neuropharmacol. 20(7):1297\u20131328.","DOI":"10.2174\/1570159X19666210712152532"},{"issue":"5","key":"5517_CR135","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1515\/hsz-2015-0295","volume":"397","author":"N Esteras","year":"2016","unstructured":"Esteras N, Dinkova-Kostova AT, Abramov AY (2016) Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function. Biol Chem 397(5):383\u2013400","journal-title":"Biol Chem"},{"key":"5517_CR136","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-04725-8","author":"R Mukherjee","year":"2025","unstructured":"Mukherjee R et al (2025) Investigating the interplay between the Nrf2\/Keap1\/HO-1\/SIRT-1 pathway and the p75NTR\/PI3K\/Akt\/MAPK cascade in neurological disorders: mechanistic insights and therapeutic innovations. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-04725-8","journal-title":"Mol Neurobiol"},{"issue":"2","key":"5517_CR137","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s12033-022-00550-9","volume":"65","author":"S Maity","year":"2023","unstructured":"Maity S, Mukherjee R, Banerjee S (2023) Recent advances and therapeutic strategies using CRISPR genome editing technique for the treatment of cancer. Mol Biotechnol 65(2):206\u2013226","journal-title":"Mol Biotechnol"},{"issue":"1","key":"5517_CR138","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7857186","volume":"2016","author":"CA Houghton","year":"2016","unstructured":"Houghton CA, Fassett RG, Coombes JS (2016) Sulforaphane and other nutrigenomic Nrf2 activators: can the clinician\u2019s expectation be matched by the reality? Oxid Med Cell Longev 2016(1):7857186","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"5517_CR139","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.14357","volume":"46","author":"KS Alharbi","year":"2022","unstructured":"Alharbi KS et al (2022) The therapeutic role of nutraceuticals targeting the Nrf2\/HO-1 signaling pathway in liver cancer. J Food Biochem 46(10):e14357","journal-title":"J Food Biochem"},{"key":"5517_CR140","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4324-2024220004","volume":"67","author":"JT Oliveira","year":"2024","unstructured":"Oliveira JT, Pieniz S (2024) Curcumin in Alzheimer\u2019s disease and depression: therapeutic potential and mechanisms of action. Braz Arch Biol Technol 67:e24220004","journal-title":"Braz Arch Biol Technol"},{"issue":"6","key":"5517_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063521","volume":"25","author":"CMC Andr\u00e9s","year":"2024","unstructured":"Andr\u00e9s CMC et al (2024) Electrophilic compounds in the human diet and their role in the induction of the transcription factor NRF2. Int J Mol Sci 25(6):3521","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5517_CR142","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/ptr.8122","volume":"38","author":"R Kakarla","year":"2024","unstructured":"Kakarla R et al (2024) Current understanding and future directions of cruciferous vegetables and their phytochemicals to combat neurological diseases. Phytother Res 38(3):1381\u20131399","journal-title":"Phytother Res"},{"key":"5517_CR143","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/978-3-030-78160-6_34","volume-title":"Plant Antioxidants and Health","author":"N Vargas-Mendoza","year":"2022","unstructured":"Vargas-Mendoza N et al (2022) The cytoprotective activity of Nrf2 Is regulated by phytochemicals (sulforaphane, curcumin, and silymarin). Plant Antioxidants and Health. Springer, pp 455\u2013505"},{"issue":"4","key":"5517_CR144","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/10408398.2018.1546668","volume":"60","author":"D Zhao","year":"2020","unstructured":"Zhao D, Simon JE, Wu Q (2020) A critical review on grape polyphenols for neuroprotection: strategies to enhance bioefficacy. Crit Rev Food Sci Nutr 60(4):597\u2013625","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"3","key":"5517_CR145","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/antiox13030303","volume":"13","author":"HR Modi","year":"2024","unstructured":"Modi HR et al (2024) Mitochondria-targeted antioxidant therapeutics for traumatic brain injury. Antioxidants 13(3):303","journal-title":"Antioxidants"},{"issue":"1","key":"5517_CR146","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12551-016-0244-4","volume":"9","author":"P Deshmukh","year":"2017","unstructured":"Deshmukh P et al (2017) The Keap1\u2013Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases. Biophys Rev 9(1):41\u201356","journal-title":"Biophys Rev"},{"key":"5517_CR147","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jchromb.2016.02.010","volume":"1019","author":"A Suneetha","year":"2016","unstructured":"Suneetha A (2016) Role of dimethyl fumarate in oxidative stress of multiple sclerosis: a review. J Chromatogr B Analyt Technol Biomed Life Sci 1019:15\u201320","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"5517_CR148","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/antiox13040455","volume":"13","author":"N Wang","year":"2024","unstructured":"Wang N, Zhang C (2024) Oxidative stress: a culprit in the progression of diabetic kidney disease. Antioxidants 13(4):455","journal-title":"Antioxidants"},{"issue":"10","key":"5517_CR149","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s10157-020-01917-5","volume":"24","author":"H Kanda","year":"2020","unstructured":"Kanda H, Yamawaki K (2020) Bardoxolone methyl: drug development for diabetic kidney disease. Clin Exp Nephrol 24(10):857\u2013864","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"5517_CR150","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8868941","volume":"2021","author":"T Zhu","year":"2021","unstructured":"Zhu T et al (2021) Classical active ingredients and extracts of Chinese herbal medicines: pharmacokinetics, pharmacodynamics, and molecular mechanisms for ischemic stroke. Oxid Med Cell Longev 2021(1):8868941","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"5517_CR151","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2174\/1570159X19666211201094608","volume":"20","author":"J Saba","year":"2022","unstructured":"Saba J et al (2022) Neuroinflammation in Huntington\u2019s disease: a starring role for astrocyte and microglia. Curr Neuropharmacol 20(6):1116\u20131143","journal-title":"Curr Neuropharmacol"},{"issue":"10","key":"5517_CR152","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1007\/s11427-021-2067-7","volume":"65","author":"J Chen","year":"2022","unstructured":"Chen J et al (2022) CRISPR-Cas9-based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: a cross-talk between FGF21 and the NRF2 pathway. Sci China Life Sci 65(10):1998\u20132016","journal-title":"Sci China Life Sci"},{"issue":"4","key":"5517_CR153","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s11481-019-09849-y","volume":"14","author":"SP Raikwar","year":"2019","unstructured":"Raikwar SP et al (2019) Next generation precision medicine: CRISPR-mediated genome editing for the treatment of neurodegenerative disorders. J Neuroimmune Pharmacol 14(4):608\u2013641","journal-title":"J Neuroimmune Pharmacol"},{"issue":"11","key":"5517_CR154","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s12519-024-00843-w","volume":"20","author":"A-J Cai","year":"2024","unstructured":"Cai A-J et al (2024) Recent advances and current status of gene therapy for epilepsy. World J Pediatr 20(11):1115\u20131137","journal-title":"World J Pediatr"},{"key":"5517_CR155","doi-asserted-by":"crossref","unstructured":"Narang JK, Dogra A, Kaur T, Narang RS, Singh AP (2025) Antioxidants against neurological disorders. In: Antioxidants: nature's defense against disease, pp 285\u2013367","DOI":"10.1002\/9781394270576.ch9"},{"key":"5517_CR156","doi-asserted-by":"publisher","first-page":"100370","DOI":"10.1016\/j.nanoso.2019.100370","volume":"19","author":"FS Anarjan","year":"2019","unstructured":"Anarjan FS (2019) Active targeting drug delivery nanocarriers: ligands. Nano-Structures & Nano-Objects 19:100370","journal-title":"Nano-Structures & Nano-Objects"},{"issue":"2","key":"5517_CR157","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/17425247.2022.2041599","volume":"19","author":"C Melim","year":"2022","unstructured":"Melim C et al (2022) Nanoparticles as phytochemical carriers for cancer treatment: news of the last decade. Expert Opin Drug Deliv 19(2):179\u2013197","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"5517_CR158","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/17425247.2021.1828339","volume":"18","author":"J Majumder","year":"2021","unstructured":"Majumder J, Minko T (2021) Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery. Expert Opin Drug Deliv 18(2):205\u2013227","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"5517_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02772-2","volume":"22","author":"W Liu","year":"2024","unstructured":"Liu W et al (2024) Targeted pathophysiological treatment of ischemic stroke using nanoparticle-based drug delivery system. J Nanobiotechnology 22(1):499","journal-title":"J Nanobiotechnology"},{"key":"5517_CR160","doi-asserted-by":"publisher","DOI":"10.2174\/0118715273325667241212041540","author":"R Bhushan","year":"2025","unstructured":"Bhushan R, Goel F, Singh S (2025) Beyond dopamine: novel therapeutic pathways for Parkinson\u2019s disease through receptor signaling. CNS & Neurological Disorders-Drug Targets. https:\/\/doi.org\/10.2174\/0118715273325667241212041540","journal-title":"CNS & Neurological Disorders-Drug Targets"},{"key":"5517_CR161","doi-asserted-by":"crossref","unstructured":"Goel F (2025) Exploring the therapeutic role of Moringa oleifera in neurodegeneration: antioxidant, anti-inflammatory, and neuroprotective mechanisms: exploring the therapeutic role of Moringa oleifera in neurodegeneration. Inflammopharmacology:1\u201317","DOI":"10.1007\/s10787-025-01794-y"},{"issue":"7","key":"5517_CR162","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s00204-020-02801-7","volume":"94","author":"S Banerjee","year":"2020","unstructured":"Banerjee S et al (2020) ROS-associated immune response and metabolism: a mechanistic approach with implication of various diseases. Arch Toxicol 94(7):2293\u20132317","journal-title":"Arch Toxicol"},{"issue":"3","key":"5517_CR163","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuint.2013.06.005","volume":"63","author":"S Sharma","year":"2013","unstructured":"Sharma S et al (2013) Biomarkers in Parkinson\u2019s disease (recent update). Neurochem Int 63(3):201\u2013229","journal-title":"Neurochem Int"},{"issue":"9","key":"5517_CR164","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1016\/j.xphs.2017.04.051","volume":"106","author":"ME Klein","year":"2017","unstructured":"Klein ME, Parvez MM, Shin J-G (2017) Clinical implementation of pharmacogenomics for personalized precision medicine: barriers and solutions. J Pharm Sci 106(9):2368\u20132379","journal-title":"J Pharm Sci"},{"issue":"10","key":"5517_CR165","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1002\/ptr.7176","volume":"35","author":"B Mangla","year":"2021","unstructured":"Mangla B et al (2021) Sulforaphane: a review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials. Phytother Res 35(10):5440\u20135458","journal-title":"Phytother Res"},{"key":"5517_CR166","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-01734-w","author":"F Goel","year":"2025","unstructured":"Goel F, Kumar D, Sharma A (2025) Impact of corticoid receptors on Alzheimer\u2019s disease: a neuroendocrine perspective. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-025-01734-w","journal-title":"Inflammopharmacology"},{"key":"5517_CR167","doi-asserted-by":"crossref","unstructured":"Bansal MP (2023) Redox regulation and therapeutic approaches in cancer. Springer","DOI":"10.1007\/978-981-99-7342-2"},{"key":"5517_CR168","doi-asserted-by":"crossref","unstructured":"Oyebanjo OT (2024) Neuropharmacology and neurotherapeutics: Advancing the understanding and treatment of neurological disorders. Biochemical and Molecular Pharmacology in Drug Discovery. Elsevier, pp 403\u2013425","DOI":"10.1016\/B978-0-443-16013-4.00019-1"},{"issue":"5","key":"5517_CR169","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10522-023-10045-y","volume":"24","author":"A Sharma","year":"2023","unstructured":"Sharma A, Singh AK (2023) Molecular mechanism of caloric restriction mimetics-mediated neuroprotection of age-related neurodegenerative diseases: an emerging therapeutic approach. Biogerontology 24(5):679\u2013708","journal-title":"Biogerontology"},{"issue":"3","key":"5517_CR170","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/antiox9030193","volume":"9","author":"E Panieri","year":"2020","unstructured":"Panieri E et al (2020) Potential applications of NRF2 modulators in cancer therapy. Antioxidants 9(3):193","journal-title":"Antioxidants"},{"key":"5517_CR171","unstructured":"Mcdougald DS (2018) Reprogramming the retina: next generation strategies of retinal neuroprotection and gene therapy vector potency assessment. Doctoral dissertation, University of Pennsylvania"},{"issue":"3","key":"5517_CR172","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41390-024-03167-7","volume":"96","author":"L Wang","year":"2024","unstructured":"Wang L et al (2024) Epigenetic modifications in the development of bronchopulmonary dysplasia: a review. Pediatr Res 96(3):632\u2013642","journal-title":"Pediatr Res"},{"key":"5517_CR173","doi-asserted-by":"crossref","unstructured":"Ali I, Adil M, Imran M, Qureshi SA, Qureshi S, Hasan N, Ahmad FJ (2025) Nanotechnology in Parkinson\u2019s disease: overcoming drug delivery challenges and enhancing therapeutic outcomes. Drug Deliv Transl Res:1\u201339","DOI":"10.1007\/s13346-025-01799-8"},{"issue":"6","key":"5517_CR174","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2174\/1568009617666171002144228","volume":"18","author":"S Sajadimajd","year":"2018","unstructured":"Sajadimajd S, Khazaei M (2018) Oxidative stress and cancer: the role of Nrf2. Curr Cancer Drug Targets 18(6):538\u2013557","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"5517_CR175","volume":"2019","author":"E Panieri","year":"2019","unstructured":"Panieri E, Saso L (2019) Potential applications of NRF2 inhibitors in cancer therapy. Oxid Med Cell Longev 2019(1):8592348","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"5517_CR176","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12964-022-00906-3","volume":"20","author":"F Pouremamali","year":"2022","unstructured":"Pouremamali F et al (2022) An update of Nrf2 activators and inhibitors in cancer prevention\/promotion. Cell Commun Signal 20(1):100","journal-title":"Cell Commun Signal"},{"issue":"1","key":"5517_CR177","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s10048-025-00828-5","volume":"26","author":"A Pal","year":"2025","unstructured":"Pal A, Goel F, Garg VK (2025) Zebrafish as a tool for autism research: unraveling the roles of Shank3, Cntnap2, Neuroligin3, and Arid1b in synaptic and behavioral abnormalities. Neurogenetics 26(1):48","journal-title":"Neurogenetics"},{"issue":"16","key":"5517_CR178","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.3390\/molecules26165001","volume":"26","author":"M Farina","year":"2021","unstructured":"Farina M et al (2021) The Nrf2 pathway in ischemic stroke: a review. Molecules 26(16):5001","journal-title":"Molecules"},{"issue":"18","key":"5517_CR179","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1089\/ars.2017.7111","volume":"28","author":"A Kumar","year":"2018","unstructured":"Kumar A, Yegla B, Foster TC (2018) Redox signaling in neurotransmission and cognition during aging. Antioxid Redox Signal 28(18):1724\u20131745","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"5517_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12017-018-08523-5","volume":"21","author":"G Bahn","year":"2019","unstructured":"Bahn G, Jo D-G (2019) Therapeutic approaches to Alzheimer\u2019s disease through modulation of NRF2. Neuromol Med 21(1):1\u201311","journal-title":"Neuromol Med"},{"key":"5517_CR181","doi-asserted-by":"publisher","DOI":"10.15584\/ejcem.2025.2.8","author":"D Kumar","year":"2025","unstructured":"Kumar D, Goel F, Rai SN (2025) The role of ABCA12 in neurodegenerative diseases\u2013a review of molecular mechanisms and potential therapeutic implications. Eur J Clin Exp Med. https:\/\/doi.org\/10.15584\/ejcem.2025.2.8","journal-title":"Eur J Clin Exp Med"},{"issue":"2","key":"5517_CR182","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/med.21757","volume":"41","author":"CC Menezes da Silveira","year":"2021","unstructured":"Menezes da Silveira CC et al (2021) Propolis: A useful agent on psychiatric and neurological disorders? A focus on CAPE and pinocembrin components. Med Res Rev 41(2):1195\u20131215","journal-title":"Med Res Rev"},{"key":"5517_CR183","doi-asserted-by":"publisher","unstructured":"Abubakar M, Giri A, Goel F, Khan M, Gupta J, Kumar D, Kaushik M, Rai SN, Kumar N (2025) Diabetes, Alzheimer's disease risk factors, and the cafeteria diet: a comprehensive review. Curr Neuropharmacol. https:\/\/doi.org\/10.2174\/011570159X384737250626094315","DOI":"10.2174\/011570159X384737250626094315"},{"issue":"1","key":"5517_CR184","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bcp.2013.06.016","volume":"87","author":"P McGonigle","year":"2014","unstructured":"McGonigle P (2014) Animal models of CNS disorders. Biochem Pharmacol 87(1):140\u2013149","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"5517_CR185","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1007\/s12035-020-01945-y","volume":"57","author":"SN Rai","year":"2020","unstructured":"Rai SN et al (2020) Mitochondrial dysfunction: a potential therapeutic target to treat Alzheimer\u2019s disease. Mol Neurobiol 57(7):3075\u20133088","journal-title":"Mol Neurobiol"},{"issue":"10","key":"5517_CR186","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1007\/s11064-023-03955-3","volume":"48","author":"K Mishra","year":"2023","unstructured":"Mishra K et al (2023) Recent advancements in nanocarrier-assisted brain delivery of phytochemicals against neurological diseases. Neurochem Res 48(10):2936\u20132968","journal-title":"Neurochem Res"},{"issue":"4","key":"5517_CR187","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41578-020-00269-6","volume":"6","author":"MT Manzari","year":"2021","unstructured":"Manzari MT et al (2021) Targeted drug delivery strategies for precision medicines. Nat Rev Mater 6(4):351\u2013370","journal-title":"Nat Rev Mater"},{"key":"5517_CR188","unstructured":"Lamas CB, Tanaka M, Laurindo LF (2024) Molecular mechanisms underlying neuroinflammation intervention with medicinal plants: a critical and narrative review of the current literature"},{"issue":"10","key":"5517_CR189","doi-asserted-by":"publisher","first-page":"627","DOI":"10.4155\/bio-2022-0080","volume":"14","author":"S Hersey","year":"2022","unstructured":"Hersey S et al (2022) 2021 white paper on recent issues in bioanalysis: ISR for biomarkers, liquid biopsies, spectral cytometry, inhalation\/oral & multispecific biotherapeutics, accuracy\/LLOQ for flow cytometry (Part 2\u2013recommendations on biomarkers\/CDx assays development & validation, cytometry validation & innovation, biotherapeutics PK LBA regulated bioanalysis, critical reagents & positive controls generation). Bioanalysis 14(10):627\u2013692","journal-title":"Bioanalysis"},{"key":"5517_CR190","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-3-031-60044-9_5","volume-title":"In Silico Clinical Trials for Cardiovascular Disease: A Finite Element and Machine Learning Approach","author":"MN \u017divanovi\u0107","year":"2024","unstructured":"\u017divanovi\u0107 MN, Filipovi\u0107 N (2024) System Biology Modeling for Drug Optimization. In Silico Clinical Trials for Cardiovascular Disease: A Finite Element and Machine Learning Approach. Springer, pp 105\u2013137"},{"issue":"13","key":"5517_CR191","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1089\/ars.2023.0234","volume":"38","author":"A Uruno","year":"2023","unstructured":"Uruno A, Yamamoto M (2023) The KEAP1-NRF2 system and neurodegenerative diseases. Antioxid Redox Signal 38(13):974\u2013988","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"5517_CR192","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","volume":"35","author":"SN Rai","year":"2019","unstructured":"Rai SN et al (2019) The role of PI3K\/Akt and ERK in neurodegenerative disorders. Neurotox Res 35(3):775\u2013795","journal-title":"Neurotox Res"},{"issue":"1","key":"5517_CR193","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1196\/annals.1427.036","volume":"1147","author":"JA Johnson","year":"2008","unstructured":"Johnson JA et al (2008) The Nrf2\u2013ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann N Y Acad Sci 1147(1):61\u201369","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"5517_CR194","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s12640-015-9519-y","volume":"27","author":"J Segura-Aguilar","year":"2015","unstructured":"Segura-Aguilar J, Kostrzewa RM (2015) Neurotoxin mechanisms and processes relevant to Parkinson\u2019s disease: an update. Neurotox Res 27(3):328\u2013354","journal-title":"Neurotox Res"},{"issue":"8","key":"5517_CR195","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3390\/pharmaceutics16081068","volume":"16","author":"K Petrikonis","year":"2024","unstructured":"Petrikonis K et al (2024) The antinociceptive role of Nrf2 in neuropathic pain: from mechanisms to clinical perspectives. Pharmaceutics 16(8):1068","journal-title":"Pharmaceutics"},{"issue":"2","key":"5517_CR196","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12013-024-01248-2","volume":"82","author":"BE Ekundayo","year":"2024","unstructured":"Ekundayo BE et al (2024) Oxidative stress, endoplasmic reticulum stress and apoptosis in the pathology of Alzheimer\u2019s disease. Cell Biochem Biophys 82(2):457\u2013477","journal-title":"Cell Biochem Biophys"},{"issue":"2","key":"5517_CR197","doi-asserted-by":"publisher","DOI":"10.3390\/jmp6020012","volume":"6","author":"UG Joseph","year":"2025","unstructured":"Joseph UG et al (2025) Dysfunctional astrocyte metabolism: a driver of imbalanced excitatory\/inhibitory tone and support for therapeutic intervention targets. J Mol Pathol 6(2):12","journal-title":"J Mol Pathol"},{"issue":"1","key":"5517_CR198","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6680935","volume":"2021","author":"R Balakrishnan","year":"2021","unstructured":"Balakrishnan R et al (2021) Natural phytochemicals as novel therapeutic strategies to prevent and treat Parkinson\u2019s disease: current knowledge and future perspectives. Oxid Med Cell Longev 2021(1):6680935","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"5517_CR199","first-page":"5021694","volume":"2020","author":"T Cunha-Oliveira","year":"2020","unstructured":"Cunha-Oliveira T et al (2020) Oxidative stress in amyotrophic lateral sclerosis: pathophysiology and opportunities for pharmacological intervention. Oxid Med Cell Longev 2020(1):5021694","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"5517_CR200","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12031-022-02084-w","volume":"73","author":"JO Emudainohwo","year":"2023","unstructured":"Emudainohwo JO et al (2023) Normalization of HPA axis, cholinergic neurotransmission, and inhibiting brain oxidative and inflammatory dynamics are associated with the adaptogenic-like effect of rutin against psychosocial defeat stress. J Mol Neurosci 73(1):60\u201375","journal-title":"J Mol Neurosci"},{"key":"5517_CR201","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.777347","volume":"15","author":"SN Rai","year":"2021","unstructured":"Rai SN et al (2021) Therapeutic potential of vital transcription factors in Alzheimer\u2019s and Parkinson\u2019s disease with particular emphasis on transcription factor EB mediated autophagy. Front Neurosci 15:777347","journal-title":"Front Neurosci"},{"issue":"3","key":"5517_CR202","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12640-019-00147-2","volume":"37","author":"SS Singh","year":"2020","unstructured":"Singh SS et al (2020) NF-\u03baB-mediated neuroinflammation in Parkinson\u2019s disease and potential therapeutic effect of polyphenols. Neurotox Res 37(3):491\u2013507","journal-title":"Neurotox Res"},{"issue":"10","key":"5517_CR203","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3390\/biomedicines9101284","volume":"9","author":"SN Rai","year":"2021","unstructured":"Rai SN et al (2021) The role of vitamins in neurodegenerative disease: an update. Biomedicines 9(10):1284","journal-title":"Biomedicines"},{"key":"5517_CR204","doi-asserted-by":"crossref","unstructured":"Naomi R, Embong H, Othman F, Ghazi HF, Maruthey N, Bahari H (2021) Probiotics for Alzheimer\u2019s disease: a systematic review. Nutrients 2022(14):20","DOI":"10.3390\/nu14010020"},{"key":"5517_CR205","volume-title":"Nrf2 mediated neuroprotection in in vitro models of Parkinson's disease","author":"A Siebert","year":"2011","unstructured":"Siebert A (2011) Nrf2 mediated neuroprotection in in vitro models of Parkinson\u2019s disease. University of Maryland, Baltimore"},{"issue":"14","key":"5517_CR206","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.2174\/1389450122666210224105945","volume":"22","author":"A Sharma","year":"2021","unstructured":"Sharma A et al (2021) Mitochondrial dysfunction in Huntington\u2019s disease: pathogenesis and therapeutic opportunities. Curr Drug Targets 22(14):1637\u20131667","journal-title":"Curr Drug Targets"},{"issue":"2","key":"5517_CR207","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11064-022-03779-7","volume":"48","author":"GL Gupta","year":"2023","unstructured":"Gupta GL, Sharma L, Sharma M (2023) 18\u03b2-Glycyrrhetinic acid ameliorates neuroinflammation linked depressive behavior instigated by chronic unpredictable mild stress via triggering BDNF\/TrkB signaling pathway in rats. Neurochem Res 48(2):551\u2013569","journal-title":"Neurochem Res"},{"key":"5517_CR208","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2023.137436","volume":"813","author":"A Farkhakfar","year":"2023","unstructured":"Farkhakfar A, Hassanpour S, Zendehdel M (2023) Resveratrol plays neuroprotective role on ketamine-induced schizophrenia-like behaviors and oxidative damage in mice. Neurosci Lett 813:137436","journal-title":"Neurosci Lett"},{"key":"5517_CR209","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.jad.2018.10.370","volume":"245","author":"SS Valvassori","year":"2019","unstructured":"Valvassori SS et al (2019) The role of neurotrophic factors in manic-, anxious-and depressive-like behaviors induced by amphetamine sensitization: implications to the animal model of bipolar disorder. J Affect Disord 245:1106\u20131113","journal-title":"J Affect Disord"},{"key":"5517_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2022.109611","volume":"376","author":"X Lin","year":"2022","unstructured":"Lin X et al (2022) Nonhuman primate models of ischemic stroke and neurological evaluation after stroke. J Neurosci Methods 376:109611","journal-title":"J Neurosci Methods"},{"key":"5517_CR211","doi-asserted-by":"crossref","unstructured":"Gencheva R (2024) Mechanisms of action of thioredoxin reductase inhibitors in the context of cancer. Doctoral dissertation, Karolinska Institutet","DOI":"10.69622\/26893846.v1"},{"issue":"4","key":"5517_CR212","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/03009858211005537","volume":"58","author":"SF Santagostino","year":"2021","unstructured":"Santagostino SF et al (2021) Mechanisms of regulated cell death: current perspectives. Vet Pathol 58(4):596\u2013623","journal-title":"Vet Pathol"},{"key":"5517_CR213","first-page":"208","volume-title":"Molecular targets and therapeutic interventions against neurodegenerative diseases","author":"RS Pal","year":"2025","unstructured":"Pal RS et al (2025) Herbs and natural products for neurodegenerative disorders. Molecular targets and therapeutic interventions against neurodegenerative diseases. CRC Press, pp 208\u2013231"},{"issue":"12","key":"5517_CR214","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-020-02532-7","volume":"10","author":"SN Rai","year":"2020","unstructured":"Rai SN et al (2020) Mucuna pruriens in Parkinson\u2019s and in some other diseases: recent advancement and future prospective. 3 Biotech 10(12):522","journal-title":"3 Biotech"},{"issue":"14","key":"5517_CR215","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1089\/ars.2020.8212","volume":"34","author":"J Meng","year":"2021","unstructured":"Meng J et al (2021) Precision redox: the key for antioxidant pharmacology. Antioxid Redox Signal 34(14):1069\u20131082","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"5517_CR216","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1080\/07388551.2021.1964431","volume":"42","author":"MP Singh","year":"2022","unstructured":"Singh MP et al (2022) Biomolecules of mushroom: a recipe of human wellness. Crit Rev Biotechnol 42(6):913\u2013930","journal-title":"Crit Rev Biotechnol"},{"key":"5517_CR217","doi-asserted-by":"publisher","first-page":"1333006","DOI":"10.3389\/fphar.2024.1333006","volume":"15","author":"W Zhang","year":"2024","unstructured":"Zhang W et al (2024) Exploring Chinese herbal medicine for ischemic stroke: insights into microglia and signaling pathways. Front Pharmacol 15:1333006","journal-title":"Front Pharmacol"},{"issue":"1","key":"5517_CR218","volume":"9","author":"N Kandezi","year":"2020","unstructured":"Kandezi N et al (2020) Novel insight to neuroprotective potential of curcumin: a mechanistic review of possible involvement of mitochondrial biogenesis and PI3\/Akt\/GSK3 or PI3\/Akt\/CREB\/BDNF signaling pathways. Int J Mol Cell Med 9(1):1","journal-title":"Int J Mol Cell Med"},{"issue":"22","key":"5517_CR219","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.2174\/0113816128337697250106001808","volume":"31","author":"C Prajapati","year":"2025","unstructured":"Prajapati C et al (2025) Untargeted metabolomics and bioactivities assessment of Xylaria ellisii, an endophytic fungus isolated from the leaf of the plant Acorus calamus Linn. Curr Pharm Des 31(22):1781\u20131799","journal-title":"Curr Pharm Des"},{"key":"5517_CR220","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-94-007-4819-4_2","volume-title":"Systems Biology in Cancer Research and Drug Discovery","author":"Y Guo","year":"2012","unstructured":"Guo Y, Yang X (2012) System Biology Approach to Study Cancer Related Pathways. Systems Biology in Cancer Research and Drug Discovery. Springer, pp 39\u201367"},{"key":"5517_CR221","unstructured":"Kilaru A, Xie LH, Zhang Q, Zhang Y (2019) Tree peony species are a novel resource for production of \u03b1-linolenic acid"},{"key":"5517_CR222","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fncel.2019.00327","volume":"13","author":"S Meng","year":"2019","unstructured":"Meng S et al (2019) Epigenetics in neurodevelopment: emerging role of circular RNA. Front Cell Neurosci 13:327","journal-title":"Front Cell Neurosci"},{"key":"5517_CR223","doi-asserted-by":"crossref","unstructured":"Sabolov\u00e1 G, Ko\u010dan L, Rabajdov\u00e1 M, Rap\u010danov\u00e1 S, Va\u0161kov\u00e1 J (2024) Association of inflammation, oxidative stress, and deteriorated cognitive functions in patients after cardiac surgery. Vessel Plus 8:N\u2013A","DOI":"10.20517\/2574-1209.2024.05"},{"issue":"1","key":"5517_CR224","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-024-01777-5","volume":"9","author":"W-W Liu","year":"2024","unstructured":"Liu W-W et al (2024) RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy. Signal Transduct Target Ther 9(1):70","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"5517_CR225","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2174\/1871527319666200812224457","volume":"19","author":"W Zahra","year":"2020","unstructured":"Zahra W et al (2020) Neuroprotection of rotenone-induced parkinsonism by ursolic acid in PD mouse model. CNS & Neurological Disorders 19(7):527\u2013540","journal-title":"CNS & Neurological Disorders"},{"issue":"2","key":"5517_CR226","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.62110\/sciencein.cbl.2025.v12.1264","volume":"12","author":"R Kumar","year":"2025","unstructured":"Kumar R et al (2025) Pathophysiology of Alzheimer\u2019s disease: advances in drug development and therapeutic innovations. Chem Biol Lett 12(2):1264\u20131264","journal-title":"Chem Biol Lett"},{"key":"5517_CR227","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00694","volume":"11","author":"M Sharifi-Rad","year":"2020","unstructured":"Sharifi-Rad M et al (2020) Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases. Front Physiol 11:552535","journal-title":"Front Physiol"},{"issue":"2","key":"5517_CR228","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1152\/physiolgenomics.00041.2017","volume":"50","author":"QM Chen","year":"2018","unstructured":"Chen QM, Maltagliati AJ (2018) Nrf2 at the heart of oxidative stress and cardiac protection. Physiol Genomics 50(2):77\u201397","journal-title":"Physiol Genomics"},{"issue":"13","key":"5517_CR229","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1007\/s00259-019-04382-9","volume":"46","author":"A Holzinger","year":"2019","unstructured":"Holzinger A, Haibe-Kains B, Jurisica I (2019) Why imaging data alone is not enough: AI-based integration of imaging, omics, and clinical data. Eur J Nucl Med Mol Imaging 46(13):2722\u20132730","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"5517_CR230","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nrd.2017.226","volume":"17","author":"SA Dugger","year":"2018","unstructured":"Dugger SA, Platt A, Goldstein DB (2018) Drug development in the era of precision medicine. Nat Rev Drug Discov 17(3):183\u2013196","journal-title":"Nat Rev Drug Discov"},{"key":"5517_CR231","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-pharmtox-052220-103416","volume":"62","author":"A Cuadrado","year":"2022","unstructured":"Cuadrado A (2022) Brain-protective mechanisms of transcription factor NRF2: toward a common strategy for neurodegenerative diseases. Annu Rev Pharmacol Toxicol 62:255\u2013277","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"12","key":"5517_CR232","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1007\/s12035-020-02083-1","volume":"57","author":"A Abdullah","year":"2020","unstructured":"Abdullah A, Mohd Murshid N, Makpol S (2020) Antioxidant modulation of mTOR and sirtuin pathways in age-related neurodegenerative diseases. Mol Neurobiol 57(12):5193\u20135207","journal-title":"Mol Neurobiol"},{"issue":"24","key":"5517_CR233","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.1113\/JP275072","volume":"595","author":"LC Pomatto","year":"2017","unstructured":"Pomatto LC, Davies KJ (2017) The role of declining adaptive homeostasis in ageing. J Physiol 595(24):7275\u20137309","journal-title":"J Physiol"},{"issue":"1","key":"5517_CR234","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7743705","volume":"2022","author":"S Shohag","year":"2022","unstructured":"Shohag S et al (2022) Perspectives on the molecular mediators of oxidative stress and antioxidant strategies in the context of neuroprotection and neurolongevity: an extensive review. Oxid Med Cell Longev 2022(1):7743705","journal-title":"Oxid Med Cell Longev"},{"key":"5517_CR235","unstructured":"Pan Y, Nicolazzo JA, Owada Y (2019) The involvement of fatty acid-binding protein 5 in the blood-brain barrier transport of docosahexaenoic acid and cognition. In: Kickoff symposium: advanced graduate program for future medicine and healthcare"},{"issue":"1","key":"5517_CR236","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/0113894501320839240918110656","volume":"26","author":"M Mohan","year":"2025","unstructured":"Mohan M et al (2025) Nrf2 and ferroptosis: exploring translational avenues for therapeutic approaches to neurological diseases. Curr Drug Targets 26(1):33\u201358","journal-title":"Curr Drug Targets"},{"issue":"3","key":"5517_CR237","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/14728222.2021.1890716","volume":"25","author":"A Mazur","year":"2021","unstructured":"Mazur A et al (2021) Nrf2 as a therapeutic target in ischemic stroke. Expert Opin Ther Targets 25(3):163\u2013166","journal-title":"Expert Opin Ther Targets"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05517-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05517-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05517-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T09:02:02Z","timestamp":1764320522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05517-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":237,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5517"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05517-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participants"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"All authors declared the absence of any financial or personal conflicts pertaining to this work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"197"}}